3′LIFE: a functional assay to detect miRNA targets in high-throughput

MicroRNAs (miRNAs) are short non-coding RNAs that regulate gene output at the post-transcriptional level by targeting degenerate elements primarily in 3′untranslated regions (3′UTRs) of mRNAs. Individual miRNAs can regulate networks of hundreds of genes, yet for the majority of miRNAs few, if any, targets are known. Misexpression of miRNAs is also a major contributor to cancer progression, thus there is a critical need to validate miRNA targets in high-throughput to understand miRNAs' contribution to tumorigenesis. Here we introduce a novel high-throughput assay to detect miRNA targets in 3′UTRs, called Luminescent Identification of Functional Elements in 3′UTRs (3′LIFE). We demonstrate the feasibility of 3′LIFE using a data set of 275 human 3′UTRs and two cancer-relevant miRNAs, let-7c and miR-10b, and compare our results to alternative methods to detect miRNA targets throughout the genome. We identify a large number of novel gene targets for these miRNAs, with only 32% of hits being bioinformatically predicted and 27% directed by non-canonical interactions. Functional analysis of target genes reveals consistent roles for each miRNA as either a tumor suppressor (let-7c) or oncogenic miRNA (miR-10b), and preferentially target multiple genes within regulatory networks, suggesting 3′LIFE is a rapid and sensitive method to detect miRNA targets in high-throughput.

[1]  S. Lindquist,et al.  Loss of tumor suppressor NF1 activates HSF1 to promote carcinogenesis. , 2012, The Journal of clinical investigation.

[2]  R. Kalluri,et al.  Methylation determines fibroblast activation and fibrogenesis in the kidney , 2010, Nature Medicine.

[3]  G. Mufti,et al.  A functional assay for microRNA target identification and validation , 2010, Nucleic acids research.

[4]  A. Lund,et al.  The miR-10 microRNA precursor family , 2011, RNA biology.

[5]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[6]  R. Birge,et al.  Crk at the Quarter Century Mark: Perspectives in Signaling and Cancer , 2014, Journal of cellular biochemistry.

[7]  Z. Songyang,et al.  Large-Scale Screens of miRNA-mRNA Interactions Unveiled That the 3′UTR of a Gene Is Targeted by Multiple miRNAs , 2013, PloS one.

[8]  S. Matsuda,et al.  Suppression of cell spreading by v-Crk requires Ras-MEK-MAP kinase signaling , 2001, Oncogene.

[9]  P. Goyette,et al.  RARgamma acts as a tumor suppressor in mouse keratinocytes. , 2004, Oncogene.

[10]  G. Daley,et al.  A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence , 2002, Nature Cell Biology.

[11]  N. Reyhani,et al.  Cancer-Predicting Gene Expression Changes in Colonic Mucosa of Western Diet Fed Mlh1 +/- Mice , 2013, PloS one.

[12]  Daoud Meerzaman,et al.  SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-beta homeostasis in lung cancer cells. , 2008, Cancer research.

[13]  J. Gu,et al.  Let‐7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer , 2012, The Journal of pathology.

[14]  K. Ohuchida,et al.  MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. , 2011, Surgery.

[15]  Jeffrey E. Green,et al.  Expression of GATA3 in MDA-MB-231 Triple-negative Breast Cancer Cells Induces a Growth Inhibitory Response to TGFß , 2013, PloS one.

[16]  J. Bharti,et al.  Evaluation of p53, HoxD10, and E-Cadherin Status in Breast Cancer and Correlation with Histological Grade and Other Prognostic Factors , 2014, Journal of oncology.

[17]  Yali Dou,et al.  Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases , 2006, Proceedings of the National Academy of Sciences.

[18]  M. Shirane,et al.  Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome , 2009, British Journal of Cancer.

[19]  M. Hallett,et al.  Stromal retinoic acid receptor β promotes mammary gland tumorigenesis , 2010, Proceedings of the National Academy of Sciences.

[20]  Wei Li,et al.  ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression , 2014, Nature.

[21]  Zuoshang Xu,et al.  A construct with fluorescent indicators for conditional expression of miRNA , 2008, BMC biotechnology.

[22]  Bryan R. Cullen,et al.  MicroRNA Target Site Identification by Integrating Sequence and Binding Information , 2013, Nature Methods.

[23]  Michael Rehli,et al.  Genome‐wide methylation screen in low‐grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  Pierre Validire,et al.  Integrated molecular portrait of non-small cell lung cancers , 2013, BMC Medical Genomics.

[25]  Chi-Ying F. Huang,et al.  miRTarBase: a database curates experimentally validated microRNA–target interactions , 2010, Nucleic Acids Res..

[26]  P. Dollé,et al.  Retinoic acid in development: towards an integrated view , 2008, Nature Reviews Genetics.

[27]  E. S. Yang,et al.  RNA interference targeting sensitive-to-apoptosis gene potentiates doxorubicin- and staurosporine-induced apoptosis of PC3 cells. , 2013, Anticancer research.

[28]  H. Friess,et al.  Smad6 suppresses TGF-beta-induced growth inhibition in COLO-357 pancreatic cancer cells and is overexpressed in pancreatic cancer. , 1999, Biochemical and biophysical research communications.

[29]  W. V. van IJcken,et al.  CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer , 2009, British Journal of Cancer.

[30]  Angela M. Liu,et al.  Two-tiered Approach Identifies a Network of Cancer and Liver Disease-related Genes Regulated by miR-122* , 2011, The Journal of Biological Chemistry.

[31]  Eugene Berezikov,et al.  Evolution of microRNA diversity and regulation in animals , 2011, Nature Reviews Genetics.

[32]  Jianying Bai,et al.  Ascl2 Knockdown Results in Tumor Growth Arrest by miRNA-302b-Related Inhibition of Colon Cancer Progenitor Cells , 2012, PloS one.

[33]  H. Drexler,et al.  Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines. , 2010, Leukemia research.

[34]  D. Bartel MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[35]  T. Golde,et al.  ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a γ-secretase inhibitor , 2008, Oncogene.

[36]  M. Privalsky,et al.  Regulation of SMRT corepressor dimerization and composition by MAP kinase phosphorylation , 2011, Molecular and Cellular Endocrinology.

[37]  Kerstin B. Meyer,et al.  Master regulators of FGFR2 signalling and breast cancer risk , 2013, Nature Communications.

[38]  W. Tan,et al.  Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. , 2011, Cancer research.

[39]  D. Moskophidis,et al.  Heat Shock Factor Hsf1 Cooperates with ErbB2 (Her2/Neu) Protein to Promote Mammary Tumorigenesis and Metastasis* , 2012, The Journal of Biological Chemistry.

[40]  Yi Li,et al.  Loss of GATA3 in bladder cancer promotes cell migration and invasion , 2014, Cancer biology & therapy.

[41]  G. Sauvageau,et al.  EN2 is a candidate oncogene in human breast cancer , 2005, Oncogene.

[42]  Shiaw-Yih Lin,et al.  Dual functions of the homeoprotein DLX4 in modulating responsiveness of tumor cells to topoisomerase II-targeting drugs. , 2013, Cancer research.

[43]  C. Mayr,et al.  Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells , 2009, Cell.

[44]  P. Goyette,et al.  RARγ acts as a tumor suppressor in mouse keratinocytes , 2004, Oncogene.

[45]  M. Tsuda,et al.  Roles for crk in cancer metastasis and invasion. , 2012, Genes & cancer.

[46]  J. Manley,et al.  RNA recognition by the human polyadenylation factor CstF , 1997, Molecular and cellular biology.

[47]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[48]  M. Chou,et al.  Atypical Mechanism of NF-κB activation by TRE17/Ubiquitin-Specific Protease 6 (USP6) oncogene and its requirement in tumorigenesis , 2011, Oncogene.

[49]  Y. Mo,et al.  Elevated lipogenesis in epithelial stem-like cell confers survival advantage in ductal carcinoma in situ of breast cancer , 2013, Oncogene.

[50]  M. Lerch,et al.  Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. , 2009, Gastroenterology.

[51]  Robert Gentleman,et al.  Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer , 2012, Nature Genetics.

[52]  R. Merrill,et al.  All-trans retinoic acid-responsive genes identified in the human SH-SY5Y neuroblastoma cell line and their regulated expression in the nervous system of early embryos , 2004, Biological chemistry.

[53]  Zhihua Liu,et al.  MicroRNA-10b Promotes Migration and Invasion through KLF4 in Human Esophageal Cancer Cell Lines* , 2010, The Journal of Biological Chemistry.

[54]  Peter J. Shepard,et al.  Complex and dynamic landscape of RNA polyadenylation revealed by PAS-Seq. , 2011, RNA.

[55]  Chung-I Wu,et al.  The evolution of evolvability in microRNA target sites in vertebrates , 2013, Genome research.

[56]  Yi Zheng,et al.  A distinct role of RhoB in gastric cancer suppression , 2011, International journal of cancer.

[57]  A. Chase,et al.  Aberrations of EZH2 in Cancer , 2011, Clinical Cancer Research.

[58]  R. Stallings,et al.  MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2 , 2011, Cell Death and Differentiation.

[59]  R. Benezra,et al.  Oncogenes and Angiogenesis: down-regulation of thrombospondin-1 in normal fibroblasts exposed to factors from cancer cells harboring mutant ras. , 2005, Cancer research.

[60]  Scott B. Dewell,et al.  Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP , 2010, Cell.

[61]  R. Schiff,et al.  PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells. , 2013, Cancer cell.

[62]  I. Bleiweiss,et al.  Retinoic acid receptor alpha2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[63]  Amit Sharma,et al.  DNASU plasmid and PSI:Biology-Materials repositories: resources to accelerate biological research , 2013, Nucleic Acids Res..

[64]  A. Giaccia,et al.  Mitogen-activated protein kinase acts as a negative regulator of the heat shock response in NIH3T3 cells. , 1995, Cancer research.

[65]  A. Toker,et al.  RhoB differentially controls Akt function in tumor cells and stromal endothelial cells during breast tumorigenesis. , 2013, Cancer research.

[66]  M. Hanna,et al.  Biodiesel production : a review , 1999 .

[67]  M. J. van de Vijver,et al.  Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. , 2011, Cell stem cell.

[68]  Michael R. Green,et al.  Oncogenic RAS directs silencing of tumor suppressor genes through ordered recruitment of transcriptional repressors , 2013, Genes & development.

[69]  Zhiyuan Shen,et al.  BCCIP regulates homologous recombination by distinct domains and suppresses spontaneous DNA damage , 2007, Nucleic acids research.

[70]  W. Filipowicz,et al.  Relief of microRNA-Mediated Translational Repression in Human Cells Subjected to Stress , 2006, Cell.

[71]  G. Crooks,et al.  WebLogo: a sequence logo generator. , 2004, Genome research.

[72]  M. Esteller,et al.  Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis , 2013, Oncogene.

[73]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[74]  A. Ross,et al.  Retinoic acid and α-galactosylceramide regulate the expression of costimulatory receptors and transcription factors responsible for B cell activation and differentiation. , 2013, Immunobiology.

[75]  Hua Yu,et al.  The STATs of cancer — new molecular targets come of age , 2004, Nature Reviews Cancer.

[76]  Xin Fu,et al.  Analysis of genetic aberrations on chromosomal region 8q21–24 identifies E2F5 as an oncogene with copy number gain in prostate cancer , 2013, Medical Oncology.

[77]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[78]  H. Noh,et al.  p53 down-regulates SETDB1 gene expression during paclitaxel induced-cell death. , 2014, Biochemical and biophysical research communications.

[79]  Hao Wang,et al.  Normal prostate‐derived stromal cells stimulate prostate cancer development , 2011, Cancer science.

[80]  M. Emmert-Buck,et al.  Deletion of the olfactomedin 4 gene is associated with progression of human prostate cancer. , 2013, The American journal of pathology.

[81]  M. Resh,et al.  Hedgehog acyltransferase as a target in pancreatic ductal adenocarcinoma , 2014, Oncogene.

[82]  J. Kitzman,et al.  Determinants of targeting by endogenous and exogenous microRNAs and siRNAs. , 2007, RNA.

[83]  C. Brenner,et al.  RGS6 suppresses Ras-induced cellular transformation by facilitating Tip60-mediated Dnmt1 degradation and promoting apoptosis , 2014, Oncogene.

[84]  Takashi Suzuki,et al.  LIN28: A regulator of tumor-suppressing activity of let-7 microRNA in human breast cancer , 2012, The Journal of Steroid Biochemistry and Molecular Biology.

[85]  E. Gabrielson,et al.  Frequent down-regulation of HIVEP2 in human breast cancer , 2005, Breast Cancer Research and Treatment.

[86]  R Tibshirani,et al.  Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification , 2006, Oncogene.

[87]  L. Lim,et al.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.

[88]  A. Ochiai,et al.  RAS oncogenic signal upregulates EZH2 in pancreatic cancer. , 2012, Biochemical and biophysical research communications.

[89]  G. Wong,et al.  Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion* , 2010, The Journal of Biological Chemistry.

[90]  Nectarios Koziris,et al.  TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support , 2011, Nucleic Acids Res..

[91]  A. Ridley RhoA, RhoB and RhoC have different roles in cancer cell migration , 2013, Journal of microscopy.

[92]  Edward W. Tate,et al.  Attenuation of Hedgehog Acyltransferase-Catalyzed Sonic Hedgehog Palmitoylation Causes Reduced Signaling, Proliferation and Invasiveness of Human Carcinoma Cells , 2014, PloS one.

[93]  B. Mankoo,et al.  Retinoic acid is both necessary for and inhibits myogenic commitment and differentiation in the chick limb. , 2010, The International journal of developmental biology.

[94]  Y. Mo,et al.  Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. , 2008, Cancer research.

[95]  V. Jordan,et al.  Estrogen regulation of X-box binding protein-1 and its role in estrogen induced growth of breast and endometrial cancer cells , 2010, Hormone molecular biology and clinical investigation.

[96]  Min Jung Park,et al.  Interaction and functional cooperation of the cancer-amplified transcriptional coactivator activating signal cointegrator-2 and E2F-1 in cell proliferation. , 2003, Molecular cancer research : MCR.

[97]  Martin Reczko,et al.  DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows , 2013, Nucleic Acids Res..

[98]  Kendall W. Cradic,et al.  Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target. , 2010, The Journal of clinical endocrinology and metabolism.

[99]  B. Barlogie,et al.  The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy. , 2007, Blood.

[100]  Yusuke Nakamura,et al.  Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population , 2010, Nature Genetics.

[101]  N. Rajewsky,et al.  The evolution of gene regulation by transcription factors and microRNAs , 2007, Nature Reviews Genetics.

[102]  F. Zhan,et al.  RARα2 expression confers myeloma stem cell features. , 2013, Blood.

[103]  Robert A. Weinberg,et al.  Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model , 2010, Nature Biotechnology.

[104]  N. Rajewsky,et al.  Widespread changes in protein synthesis induced by microRNAs , 2008, Nature.

[105]  P. Meltzer,et al.  Activating Signal Cointegrator 2 Belongs to a Novel Steady-State Complex That Contains a Subset of Trithorax Group Proteins , 2003, Molecular and Cellular Biology.

[106]  R. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.

[107]  Ligang Wu,et al.  Micro-RNA Regulation of the Mammalian lin-28 Gene during Neuronal Differentiation of Embryonal Carcinoma Cells , 2005, Molecular and Cellular Biology.

[108]  M. Stoffel,et al.  MicroRNA-96 Directly Inhibits γ-Globin Expression in Human Erythropoiesis , 2011, PloS one.

[109]  Bruce T. Lahn,et al.  Systematic Comparison of Constitutive Promoters and the Doxycycline-Inducible Promoter , 2010, PloS one.

[110]  K. White,et al.  Genomic Antagonism between Retinoic Acid and Estrogen Signaling in Breast Cancer , 2009, Cell.

[111]  T. Sugimura,et al.  Identification of 20 genes aberrantly methylated in human breast cancers , 2005, International journal of cancer.

[112]  Z. Werb,et al.  GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression , 2013, Nature Cell Biology.

[113]  H. Feilotter,et al.  miR-193b Regulates Mcl-1 in Melanoma. , 2011, The American journal of pathology.

[114]  George Easow,et al.  Isolation of microRNA targets by miRNP immunopurification. , 2007, RNA.

[115]  K. Ross,et al.  Characterization of Notch1 Antibodies That Inhibit Signaling of Both Normal and Mutated Notch1 Receptors , 2010, PloS one.

[116]  R. Rodriguez,et al.  A noncommercial dual luciferase enzyme assay system for reporter gene analysis. , 2000, Analytical biochemistry.

[117]  C. Litterst,et al.  Transcriptional Activation by STAT6 Requires the Direct Interaction with NCoA-1* , 2001, The Journal of Biological Chemistry.

[118]  Margaret S. Ebert,et al.  Roles for MicroRNAs in Conferring Robustness to Biological Processes , 2012, Cell.

[119]  Michael R. Green,et al.  An elaborate pathway required for Ras-mediated epigenetic silencing , 2007, Nature.

[120]  A. Clarke,et al.  Entopic overexpression of Ascl2 does not accelerate tumourigenesis in ApcMin mice , 2011, Gut.

[121]  Guan Sun,et al.  MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10 , 2011, Brain Research.

[122]  W. Grizzle,et al.  Syndecan-1 overexpression is associated with nonluminal subtypes and poor prognosis in advanced breast cancer. , 2013, American journal of clinical pathology.

[123]  E. Flemington,et al.  MicroRNA miR-155 Inhibits Bone Morphogenetic Protein (BMP) Signaling and BMP-Mediated Epstein-Barr Virus Reactivation , 2010, Journal of Virology.

[124]  Anna M. Krichevsky,et al.  Context effect: microRNA-10b in cancer cell proliferation, spread and death , 2011, Autophagy.

[125]  H. Guan,et al.  Annexin A7 suppresses lymph node metastasis of hepatocarcinoma cells in a mouse model , 2013, BMC Cancer.

[126]  W. Gerald,et al.  An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen , 2006, Oncogene.

[127]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[128]  K. Pollard,et al.  Detection of nonneutral substitution rates on mammalian phylogenies. , 2010, Genome research.

[129]  T. Pandita,et al.  E2FBP1 antagonizes the p16INK4A-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability , 2011, International Journal of Oral Science.

[130]  E. Kistner,et al.  Let-7 expression defines two differentiation stages of cancer , 2007, Proceedings of the National Academy of Sciences.

[131]  M. Raffeld,et al.  ANXA7 expression represents hormone‐relevant tumor suppression in different cancers , 2007, International journal of cancer.

[132]  Y. Yatabe,et al.  Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.

[133]  Nicolás Peláez,et al.  Biological robustness and the role of microRNAs: a network perspective. , 2012, Current topics in developmental biology.

[134]  Sebastian D. Mackowiak,et al.  The Landscape of C. elegans 3′UTRs , 2010, Science.

[135]  Michael J. Terry,et al.  HOX gene clusters are hotspots of de novo methylation in CpG islands of human lung adenocarcinomas , 2002, Oncogene.

[136]  A. Svindland,et al.  Regulation of PBX3 expression by androgen and Let-7d in prostate cancer , 2011, Molecular Cancer.

[137]  V. Thakur,et al.  Multifaceted role of EZH2 in breast and prostate tumorigenesis , 2013, Epigenetics.

[138]  H. Salih,et al.  Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA , 2006, Cancer Immunology, Immunotherapy.

[139]  E. Paltrinieri,et al.  let-7 and miR-140 microRNAs coordinately regulate skeletal development , 2013, Proceedings of the National Academy of Sciences.

[140]  D. Bartel,et al.  The impact of microRNAs on protein output , 2008, Nature.

[141]  D. Yee,et al.  STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells. , 2002, Neoplasia.

[142]  S. Chi,et al.  An alternative mode of microRNA target recognition , 2012, Nature Structural &Molecular Biology.

[143]  Patrice M. Milos,et al.  An in-depth map of polyadenylation sites in cancer , 2012, Nucleic acids research.

[144]  S. Filetti,et al.  Cyclic AMP-response element modulator inhibits the promoter activity of the sodium iodide symporter gene in thyroid cancer cells. , 2012, Thyroid : official journal of the American Thyroid Association.

[145]  Tanya Stoyanova,et al.  Collaboration of Kras and androgen receptor signaling stimulates EZH2 expression and tumor-propagating cells in prostate cancer. , 2012, Cancer research.

[146]  M. Campbell,et al.  Transcription factor co‐repressors in cancer biology: roles and targeting , 2010, International journal of cancer.

[147]  T. Khoury,et al.  Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer , 2013, Oncotarget.

[148]  Deepa Subramanyam,et al.  Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis , 2009, Molecular Cancer.

[149]  S. Lindquist,et al.  Heat Shock Factor 1 Is a Powerful Multifaceted Modifier of Carcinogenesis , 2007, Cell.

[150]  M. Washington,et al.  SPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity. , 2013, Gastroenterology.

[151]  N. Xi,et al.  Inactivation of SAG E3 Ubiquitin Ligase Blocks Embryonic Stem Cell Differentiation and Sensitizes Leukemia Cells to Retinoid Acid , 2011, PloS one.

[152]  C. Croce,et al.  Targeting microRNAs in cancer: rationale, strategies and challenges , 2010, Nature Reviews Drug Discovery.

[153]  N. Tsuji,et al.  Specific overexpression of OLFM4GW112/hGC−1 mRNA in colon, breast and lung cancer tissues detected using quantitative analysis , 2007, Cancer science.

[154]  张伟,et al.  Oncogenic Activity of Retinoic Acid Receptor gamma Is Exhibited through Activation of the Akt/NF-kappa B and Wnt/beta-Catenin Pathways in Cholangiocarcinoma , 2013 .

[155]  Gideon Rechavi,et al.  Gene expression regulation mediated through reversible m6A RNA methylation , 2014, Nature Reviews Genetics.

[156]  G. Bepler,et al.  ID1 Facilitates the Growth and Metastasis of Non-Small Cell Lung Cancer in Response to Nicotinic Acetylcholine Receptor and Epidermal Growth Factor Receptor Signaling , 2011, Molecular and Cellular Biology.

[157]  R. Kramer,et al.  Sdc1 negatively modulates carcinoma cell motility and invasion. , 2010, Experimental cell research.

[158]  F. Slack,et al.  A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. , 2008, Cancer research.

[159]  Kyle Kai-How Farh,et al.  Expanding the microRNA targeting code: functional sites with centered pairing. , 2010, Molecular cell.

[160]  Geoffrey Childs,et al.  Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. , 2009, The American journal of pathology.

[161]  N. Hayashi,et al.  Serum levels of soluble major histocompatibility complex (MHC) class I‐related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma , 2008, Cancer science.

[162]  J. Bishop,et al.  Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response , 2008, Proceedings of the National Academy of Sciences.

[163]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[164]  A. Graybiel,et al.  Crk Activation of JNK via C3G and R-Ras* , 2000, The Journal of Biological Chemistry.

[165]  Yingyan Yu,et al.  Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone , 2014, BMC Cancer.

[166]  D. Fisher,et al.  Mechanism of regulation and suppression of melanoma invasiveness by novel retinoic acid receptor-gamma target gene carbohydrate sulfotransferase 10. , 2009, Cancer research.

[167]  C. Molina,et al.  Ras‐induced melanoma transformation is associated with the proteasomal degradation of the transcriptional repressor ICER , 2013, Molecular carcinogenesis.

[168]  J. Rutka,et al.  The ARF tumor suppressor controls ribosome biogenesis by regulating the RNA polymerase I transcription factor TTF-I. , 2010, Molecular cell.

[169]  D. Tollervey,et al.  Mapping the Human miRNA Interactome by CLASH Reveals Frequent Noncanonical Binding , 2013, Cell.

[170]  T. Eberlein,et al.  Specific Activation of Retinoic Acid Receptors (RARs) and Retinoid X Receptors Reveals a Unique Role for RARγ in Induction of Differentiation and Apoptosis of S91 Melanoma Cells* , 1997, The Journal of Biological Chemistry.

[171]  Yunhong Zha,et al.  Functional Dissection of HOXD Cluster Genes in Regulation of Neuroblastoma Cell Proliferation and Differentiation , 2012, PloS one.

[172]  Junjiang Fu,et al.  DLX4 Upregulates TWIST and Enhances Tumor Migration, Invasion and Metastasis , 2012, International journal of biological sciences.

[173]  Kai Zhang,et al.  A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding , 2014, Nature Genetics.

[174]  M. Lacroix-Triki,et al.  RhoB modifies estrogen responses in breast cancer cells by influencing expression of the estrogen receptor , 2013, Breast Cancer Research.

[175]  S. Ichwan,et al.  E2FBP1/DRIL1, an AT-rich interaction domain-family transcription factor, is regulated by p53. , 2003, Molecular cancer research : MCR.

[176]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[177]  W. Shi,et al.  Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL. , 2013, Blood.

[178]  H. Esumi,et al.  Induction of cell-cell detachment during glucose starvation through F-actin conversion by SNARK, the fourth member of the AMP-activated protein kinase catalytic subunit family. , 2003, Biochemical and biophysical research communications.

[179]  T. Marr,et al.  Computational analysis of 3'-ends of ESTs shows four classes of alternative polyadenylation in human, mouse, and rat. , 2005, Genome research.

[180]  C. Burge,et al.  The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution , 2005, Science.

[181]  Larissa Belov,et al.  All-trans retinoic acid induces different immunophenotypic changes on human HL60 and NB4 myeloid leukaemias. , 2008, Leukemia research.

[182]  Oliver Hofmann,et al.  miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. , 2009, Molecular cell.

[183]  C. Redfern,et al.  Overexpression of RARγ increases death of SH-SY5Y neuroblastoma cells in response to retinoic acid but not fenretinide , 2006, Cell Death and Differentiation.

[184]  Jun Chen,et al.  The integral nuclear membrane protein nurim plays a role in the suppression of apoptosis. , 2012, Current molecular medicine.

[185]  V. Haucke,et al.  The oncogenic TBC domain protein USP6/TRE17 regulates cell migration and cytokinesis , 2012, Biology of the cell.

[186]  C. Yee,et al.  Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation , 2002, Nature.

[187]  H. Hermeking,et al.  Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc , 2004, Oncogene.

[188]  Gang Rui,et al.  Oncogenic Activity of Retinoic Acid Receptor γ Is Exhibited through Activation of the Akt/NF-κB and Wnt/β-Catenin Pathways in Cholangiocarcinoma , 2013, Molecular and Cellular Biology.

[189]  Job Harms,et al.  THE LANDSCAPE OF , 2010 .

[190]  T. Ochiya,et al.  Susceptibility of Snark‐deficient mice to azoxymethane‐induced colorectal tumorigenesis and the formation of aberrant crypt foci , 2008, Cancer science.

[191]  B. Haddad,et al.  Amplification of the BP1 homeobox gene in breast cancer. , 2008, Cancer genetics and cytogenetics.

[192]  Mirko Cevec,et al.  NMR structure of the let-7 miRNA interacting with the site LCS1 of lin-41 mRNA from Caenorhabditis elegans , 2010, Nucleic acids research.

[193]  Xiwen Cheng,et al.  G Protein Pathway Suppressor 2 (GPS2) Is a Transcriptional Corepressor Important for Estrogen Receptor α-mediated Transcriptional Regulation* , 2009, The Journal of Biological Chemistry.

[194]  A. Weeraratna,et al.  Direct and indirect effects of retinoic acid on human Th2 cytokine and chemokine expression by human T lymphocytes , 2006, BMC Immunology.

[195]  T Takahashi,et al.  Identification of a metastasis signature and the DLX4 homeobox protein as a regulator of metastasis by combined transcriptome approach , 2007, Oncogene.

[196]  M. Shepelev,et al.  The RHOV gene is overexpressed in human non-small cell lung cancer. , 2013, Cancer genetics.

[197]  Jaw-Yuan Wang,et al.  EVI2B, ATP2A2, S100B, TM4SF3, and OLFM4 as potential prognostic markers for postoperative Taiwanese colorectal cancer patients. , 2012, DNA and cell biology.

[198]  S. Bose,et al.  Oncogenic Role of Engrailed-2 (En-2) in Prostate Cancer Cell Growth and Survival , 2008, Translational oncogenomics.

[199]  Rameen Beroukhim,et al.  An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB , 2010, Nature Medicine.

[200]  Andreas Keller,et al.  MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors , 2012, PloS one.

[201]  Joshua J. Steffan,et al.  The Transcription Factor SPDEF Suppresses Prostate Tumor Metastasis* , 2012, The Journal of Biological Chemistry.

[202]  T. Lu,et al.  Loss of USF transcriptional activity in breast cancer cell lines , 1999, Oncogene.

[203]  Y. Jeng,et al.  The stem cell E3‐ligase Lin‐41 promotes liver cancer progression through inhibition of microRNA‐mediated gene silencing , 2013, The Journal of pathology.

[204]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[205]  P. Sharp,et al.  Proliferating Cells Express mRNAs with Shortened 3' Untranslated Regions and Fewer MicroRNA Target Sites , 2008, Science.

[206]  Zhiyuan Shen,et al.  Genomic structure of the human BCCIP gene and its expression in cancer. , 2003, Gene.

[207]  P. Ye,et al.  Oncogenic potential of retinoic acid receptor-gamma in hepatocellular carcinoma. , 2010, Cancer research.